KYTX
Kyverna Therapeutics, Inc.
$9.68
+0.52 (+5.68%)
At close · Jul 7
Market Cap
$588.50M
Shares
60,795,212
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-04-17 | KAREN WALKER | Officer | 10,000 | 2026-04-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-14 | KAREN WALKER | Officer | 2,459 | 2026-04-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-07 | DANIEL SPIEGELMAN | Director | 17,578 | 2026-04-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-31 | DANIEL SPIEGELMAN | Director | 16,634 | 2026-03-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-15 | KAREN WALKER | Officer | 23,998 | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–5 of 5 filings